NLRP3 and retinal disorder: The objectives of the present study were to report four newly recognized kinds of retinopathy in NLRP3-AID patients, as well as to provide all the ophthalmologic manifestations of NLRP3-AID in a single-center cohort of NLRP3-AID patients diagnosed after 2015.